Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Beauty Health ( (SKIN) ) is now available.
On April 17, 2026, the company expanded its board from nine to eleven directors and appointed medical device operations executive Kenneth Tripp, plastic surgeon and aesthetics innovator Dr. Sachin Shridharani, and veteran beauty and consumer-products leader E. Scott Beattie, all deemed independent and assigned to key board committees. The company also decided that existing directors Desiree Gruber and Dr. Philippe Schaison would not stand for reelection at the 2026 annual meeting, after which the board is expected to revert to nine members, underscoring a refresh of governance and strategic expertise.
On April 21–22, 2026, the company implemented a corporate rebrand, changing its name to SkinHealth Systems Inc. via a charter amendment effective April 22, while retaining its Nasdaq ticker “SKIN” and restating its charter and bylaws to reflect the new identity and updated governance procedures. The rebrand signals a shift toward operating with the rigor of leading medical device companies, with a focus on clinically backed skin health technologies, improved device utilization across its 36,000-plus global installed base, and strengthened positioning as a science-driven medical aesthetics platform.
The most recent analyst rating on (SKIN) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Beauty Health stock, see the SKIN Stock Forecast page.
Spark’s Take on SKIN Stock
According to Spark, TipRanks’ AI Analyst, SKIN is a Neutral.
The score is held back primarily by shrinking revenue, ongoing GAAP losses, and an aggressively leveraged balance sheet. Recent positives—strong gross margins, improved operating/free cash flow, and earnings-call guidance for positive adjusted EBITDA—partly offset those risks, but weak technical momentum and a litigation/governance overhang keep the overall profile below average.
To see Spark’s full report on SKIN stock, click here.
More about Beauty Health
SkinHealth Systems, formerly The Beauty Health Company, operates in the global medical aesthetics industry, offering an integrated ecosystem of clinically proven skin health solutions. Anchored by its Hydrafacial professional skincare treatment and complemented by devices such as SkinStylus microneedling and HydraScalp with Keravive, the company targets providers worldwide through a device-plus-consumables model and omnichannel distribution.
Average Trading Volume: 696,056
Technical Sentiment Signal: Sell
Current Market Cap: $112.9M
Find detailed analytics on SKIN stock on TipRanks’ Stock Analysis page.